Pharmacokinetic/pharmacodynamic analysis of tacrolimus-induced QT prolongation in guinea pigs.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Biological and Pharmaceutical Bulletin

• Publication date

  1999-12-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1248/BPB.22.1341PMID 10746167
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sustained QT prolongation induced by tacrolimus in guinea pigs.

  1999cited by this paper
• Characterization of the pharmacodynamic interaction between parent drug and active metabolite in vivo: midazolam and alpha-OH-midazolam.

  1999cited by this paper
• Modeling of Pharmacokinetic/Pharmacodynamic (PK/PD) Relationships: Concepts and Perspectives

  1999cited by this paper
• Pharmacokinetic–pharmacodynamic analysis of the arrhythmogenic potency of a novel antiallergic agent, ebastine, in rats

  1999cited by this paper
• Pharmacodynamic analysis of the electrocardiographic interaction between disopyramide and erythromycin in rats.

  1999cited by this paper
• Immunosuppressive strategies in transplantation.

  1999cited by this paper
• Relationship between area under the concentration versus time curve of cyclosporin A, creatinine clearance, hematocrit value, and other clinical factors in Japanese renal transplant patients.

  1998cited by this paper
• Effects of hypokalaemia on arrhythmogenic risk of quinidine in rats.

  1998cited by this paper
• QT prolongation and near fatal cardiac arrhythmia after intravenous tacrolimus administration: a case report.

  1998cited by this paper
• Simple Understanding and Optimistic Strategy for Coping with Atopic Diseases

  1998cited by this paper
• Sinus arrest during tacrolimus (FK506) and digitalis treatment in a bone marrow transplant recipient.

  1997cited by this paper
• Bradycardia Associated with Intravenous Administration of Tacrolimus in a Liver Transplant Recipient

  1997cited by this paper
• Effect of hematocrit and albumin concentration on hepatic clearance of tacrolimus (FK506) during rabbit liver perfusion.

  1997cited by this paper
• Mathematical Formalism for the Properties of Four Basic Models of Indirect Pharmacodynamic Responses

  1997cited by this paper
• A Comparative Pharmacokinetic‐Pharmacodynamic Study of the Electrocardiographic Effects of Epinastine and Terfenadine in Rats

  1997cited by this paper
• Characterization of four basic models of indirect pharmacodynamic responses

  1996cited by this paper
• Erythrocyte-to-plasma distribution ratio of cyclosporine: a useful indicator to predict cyclosporine pharmacokinetics and physiological changes during cyclosporine monitoring.

  1996cited by this paper
• Pharmacokinetic-pharmacodynamic analysis of the electrocardiographic effects of terfenadine and quinidine in rats.

  1996cited by this paper
• Relationship between apparent total body clearance of cyclosporin A and its erythrocyte-to-plasma distribution ratio in renal transplant patients.

  1995cited by this paper
• Consensus document: therapeutic monitoring of tacrolimus (FK-506).

  1995cited by this paper
• Clinical Pharmacokinetics of Tacrolimus

  1995cited by this paper
• Distribution and Protein Binding of FK506, a Potent Immunosuppressive Macrolide Lactone, in Human Blood and Its Uptake by Erythrocytes

  1994cited by this paper
• A simple method for predicting the cyclosporin A erythrocyte-to-plasma distribution ratio in blood, and its clinical assessment.

  1994cited by this paper
• Relationship between QaT and RR intervals in rats, guinea pigs, rabbits, and primates.

  1994cited by this paper
• Pharmacokinetics, dosing principles, and blood level monitoring of FK506.

  1994cited by this paper
• Disposition of tacrolimus (FK 506) in rabbits. Role of red blood cell binding in hepatic clearance.

  1993cited by this paper
• QT prolongation and Torsades de Pointes after administration of FK506.

  1992cited by this paper
• Effect of temperature and hematocrit on plasma concentration of FK 506.

  1991cited by this paper
• Pharmacokinetic study of FK 506 in the rat.

  1991cited by this paper
• Relative electrophysiological potencies of quinidine, 3-OH quinidine and quinidine-N-oxide in guinea-pig heart.

  1989cited by this paper
• Pharmacodynamics of 3-hydroxyquinidine alone and in combination with quinidine in healthy persons.

  1987cited by this paper
• Method for stable measurement of the electrocardiogram in isolated guinea pig heart. Evaluation of the RR-QT relationship and the effect of quinidine.

  1987cited by this paper
• Kinetics and electrocardiographic changes after oral 3‐OH‐quinidine in healthy subjects

  1985cited by this paper
• The effect of quinidine and its metabolites on the electrocardiogram and systolic time intervals: concentration--effect relationships.

  1981cited by this paper
• A pharmacokinetic analysis program (multi) for microcomputer.

  1981cited by this paper

• A case of tacrolimus-induced supraventricular arrhythmia after kidney transplantation

  2013cites this paper
• FKBP12 Is a Critical Regulator of the Heart Rhythm and the Cardiac Voltage-Gated Sodium Current in Mice

  2011cites this paper
• Molecular Medicine FKBP 12 Is a Critical Regulator of the Heart Rhythm and the Cardiac Voltage-Gated Sodium Current in Mice

  2011cites this paper
• Cardiac and haemodynamic effects of tacrolimus in the halothane-anaesthetized dog.

  2009cites this paper
• Reduction of repolarization reserve by halothane anaesthesia sensitizes the guinea‐pig heart for drug‐induced QT interval prolongation

  2005cites this paper
• Pharmacokinetic-pharmacodynamic modeling in the data analysis and interpretation of drug-induced QT/QTc prolongation

  2005cites this paper
• Cardiovascular parameters in anaesthetized guinea pigs: a safety pharmacology screening model.

  2005cites this paper
• In vivo measurement of QT prolongation, dispersion and arrhythmogenesis: application to the preclinical cardiovascular safety pharmacology of a new chemical entity

  2002cites this paper
• Tacrolimus-induced life-threatening arrhythmia in a pediatric liver-transplant patient

  2002cites this paper
• Organising evidence on QT prolongation and occurrence of Torsades de Pointes with non-antiarrhythmic drugs: a call for consensus

  2001cites this paper
• Quantitative Relationship Between Myocardial Concentration of Tacrolimus and QT Prolongation in Guinea Pigs: Pharmacokinetic/Pharmacodynamic Model Incorporating a Site of Adverse Effect

  2001cites this paper